SCHEMBL6447770

SCHEMBL6447770

CCc1ccccc1CNC(=O)c1cc(-c2ccccc2)nc2ccccc12

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 3/20 0.75
CYP2C9 P11712 2/20 0.69
LMNA P02545 5/20 0.66
ALDH1A1 P00352 7/20 0.66
KDM4E B2RXH2 5/20 0.66
SMN1; SMN2 Q16637 2/20 0.65
MAPK1 P28482 1/20 0.65
TP53 P04637 3/20 0.64
HPGD P15428 2/20 0.64
HTT P42858 2/20 0.64
NPC1 O15118 1/20 0.64
RAB9A P51151 1/20 0.64
MEN1 O00255 1/20 0.62
POLB P06746 1/20 0.62
KMT2A Q03164 1/20 0.62
TSHR P16473 1/20 0.62
TACR2 P21452 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6448423 0.92 TACR3 (0.70) TACR3CYP2C9LMNAALDH1A1KDM4E
SCHEMBL6450086 0.86 TACR3 (1.00) TACR3CYP2C9LMNAALDH1A1KDM4E
SCHEMBL4466010 0.84 LMNA (0.67) TACR3CYP2C9LMNAALDH1A1KDM4E
SCHEMBL6451780 0.84 TACR3 (0.69) TACR3CYP2C9LMNAALDH1A1KDM4E
SCHEMBL4464898 0.83 LMNA (0.73) TACR3CYP2C9LMNAALDH1A1KDM4E
SCHEMBL5049690 0.82 TACR3 (0.70) TACR3LMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL14623959 0.82 TACR3 (0.72) TACR3LMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL10391576 0.81 TACR3 (0.76) TACR3LMNAALDH1A1KDM4ESMN1; SMN2
SCHEMBL28806102 0.81 TACR3 (0.83) TACR3CYP2C9LMNAALDH1A1KDM4E
Hydrochloric Acid SCHEMBL6969107 0.80 TACR3 (0.71) TACR3LMNAALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517708-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS Pfizer Products Inc. (US) 2005-03-30 EP claimed
WO-2004000355-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2003-12-31 WO claimed